Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 3;10:590707. doi: 10.3389/fonc.2020.590707

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Ranieri, Laface, Laforgia, De Summa, Porcelli, Macina, Ammendola, Molinari, Lauletta, Di Palo, Rubini, Ferrari and Gadaleta

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

ceCT and ¹⁸F-FDG PET/CT in a patient affected by colon cancer with lung metastasis. A 79-year-old male affected by colorectal cancer with lung metastasis, subjected to 12 cycles of Bevacizumab-based chemotherapy and 24 DEHY sessions on the thorax as first-line therapy. Baseline ceCT (A) showed metastasis in the middle lobe (red arrows). Baseline whole body ¹⁸F-FDG PET/CT (B) confirmed lung involvement by the increased ¹⁸F-FDG uptake (red arrows) detectable axial fused PET/CT images in the same site. Timepoint-2 ceCT (C) and ¹⁸F-FDG PET/CT (D) evaluation demonstrated CR of lung metastasis.